Musculoskeletal-induced Nucleation in Altitude Decompression Sickness by Conkin, J. et al.
MUSCULOSKELETAL-INDUCED NUCLEATION IN ALTITUDE DECOMPRESSION SICKNESS 
N.W. Pollock1, M.J. Natoli1, J. Conkin2, J.H. Wessel III3, M.L. Gernhardt4 
1 Center for Hyperbaric Medicine and Environmental Physiology, Duke University Medical Center, Durham, NC 
27710; 2 University Space Research Association, 3600 Bay Area Blvd, Houston, TX 77058; 3 Wyle Integrated 
Science and Engineering Group, 1290 Hercules, Houston, TX 77058; 4 NASA Johnson Space Center, 2100 NASA 
Parkway, Houston, TX 77058 
 
INTRODUCTION 
Musculoskeletal activity has the potential to both improve and compromise decompression safety. Exercise 
enhances inert gas elimination during oxygen breathing prior to decompression (prebreathe), but it may also 
promote bubble nuclei formation (nucleation), which can lead to gas phase separation and bubble growth and 
increase the risk of decompression sickness (DCS). The timing, pattern and intensity of musculoskeletal activity and 
the level of tissue supersaturation may be critical to the net effect. There are limited data available to evaluate cost-
benefit relationships. Understanding the relationship is important to improve our understanding of the underlying 
mechanisms of nucleation in exercise prebreathe protocols and to quantify risk in gravity and microgravity 
environments. Data gathered during NASA's Prebreathe Reduction Program (PRP) studies combined oxygen 
prebreathe and exercise followed by low pressure (4.3 psi; altitude equivalent of 30,300 ft [9,235 m]) microgravity 
simulation to produce two protocols used by astronauts preparing for extravehicular activity. Both the Phase 
II/CEVIS (cycle ergometer vibration isolation system) and ISLE (in-suit light exercise) trials eliminated ambulation 
to more closely simulate the microgravity environment. The CEVIS results (35 male, 10 female) serve as control 
data for this NASA/Duke study to investigate the influence of ambulation exercise on bubble formation and the 
subsequent risk of DCS.  
 
METHODS 
Four experiments will replicate the CEVIS exercise-enhanced oxygen prebreathe protocol, each with a different 
exception. The first of these is currently underway. Experiment 1 – Subjects complete controlled ambulation 
(walking in place with fixed cadence and step height) during both preflight and at 4.3 psi instead of remaining non-
ambulatory throughout. Experiment 2 – Subjects remain non-ambulatory during the preflight period and 
ambulatory at 4.3 psi. Experiment 3 – Subjects ambulate during the preflight period and remain non-ambulatory at 
4.3 psi. Experiment 4 – The order of heavy and light exercise employed in the CEVIS protocol is reversed, with the 
light exercise occurring first (subjects remain non-ambulatory throughout). Decompression stress is assessed with 
non-invasive ultrasound during each of 14 epochs of a 4 hour simulated spacewalk at 4.3 psi; aural Doppler is used 
to monitor bubbles (Spencer grade 0-IV scale) passing through the pulmonary artery, and two-dimensional 
echocardiographic imaging is used to look for gas emboli in the left heart (the presence of which is a test termination 
criterion). Venous blood is collected at baseline and twice following repressurization to determine if the 
decompression stress is correlated with microparticles (cell fragments) accumulation. The plan is to test a minimum 
of 25 and a maximum of 50 subjects in each experiment. A Fisher Exact Test is used to compare test and control 
groups. Trials are suspended when the DCS or grade IV VGE observations provide 70% confidence of DCS risk 
>15% and grade IV VGE risk >20%.  
 
RESULTS 
A total of 11 Experiment 1 trials have been completed (9 male, 2 female). The observed DCS was significantly 
greater in Experiment 1 than CEVIS trials (3/11 [27%] vs. 0/45 [0%], respectively, p=0.03). Statistical significance 
was not reached for the increase in peak grade IV VGE (2/11 [18%] vs. 3/45 [7%], p=0.149) or cumulative grade IV 
VGE observations per subject across all trial epochs (8/128 [6%] vs. 26/630 [4%], p=0.151). Microparticle data 
were collected for 5/11 trials (3 with DCS outcomes), showing widely varying patterns that cannot yet adequately be 
resolved statistically. Following a review of all study data, the data safety monitoring board agreed for Experiment 1 
trials to continue with the intent of reaching the planned 25 subject minimum, with any further cases of DCS 
prompting immediate reevaluation.  
 
DISCUSSION 
The results of the Experiment 1 trials support the thesis that decompression stress is increased by ambulation 
exercise, given the higher incidence of DCS when compared to the non-ambulatory PRP CEVIS trials. Additional 
Experiment 1 trials may improve the statistical power to assess differences in VGE and to evaluate the relationship 
between decompression stress and microparticle accumulation. Future experiments will test whether ambulation at 
altitude during supersaturated conditions generates greater decompression stress than ambulation at ground level 
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during undersaturated conditions (Experiments 2 and 3) and whether light exercise facilitates the removal of heavy 
exercise induced nucleation (Experiment 4).  
